Showing 561-570 of 3013 results for "".
What Do You Expect?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-do-you-expect/18751/By Emmy Graber, MD and Seemal R. Desai, MDDo you always show prospective patients your best photos? Sometimes it's good to show the average result. Dr. Graber discusses this and other aspects of expectation management for cosmetic interventions.Understanding the Cosmetic Patient
https://practicaldermatology.com/topics/practice-management/understanding-the-cosmetic-patient/18785/Laurie Hurt, Marketing Director for Cosmetic Surgery and Dermatology at CareCredit, shares insights on the research and buying habits of cosmetic surgery patients gleaned from The Path to Purchase Study.The Internet of Things in the Medical Office
https://practicaldermatology.com/topics/practice-management/the-internet-of-things-in-the-medical-office/21029/How technology is changing the way we can collect data, provide services, and market opportunities to our patients.Travelers Beware: Infectious Skin Dermatoses
https://practicaldermatology.com/topics/general-topics/travelers-beware-infectious-skin-dermatoses/18691/Theodore Rosen, MD and Natasha Mesinkovska, MD talk to Derm Insider host Neal Bhatia, MD about traveler maladies that affect the skin. Drs. Rosen and Mesinkovska run down diagnostic and treatment pearls for conditions ranging from parasitic infections to bed bug bites to emerging infections. They alNavigating Organizational Politics
https://practicaldermatology.com/topics/practice-management/navigating-organizational-politics/18854/Seemal Desai, MD offer tips for navigating and managing organizational politics to avoid career missteps. He also shares strategies for influencing others to help accomplish your goals in your professional and personal life.Cellfina Cleared, Finacea Foam Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-cellfina-cleared-finacea-foam-approved/18866/The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 years. Finacea Foam (azelaic acid, Bayer Dermatology) is approved for Rosacea, and Almirall invests in Suneva Medical, maker of Bellafill. Also in this edition, a look at the data oPipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigRecently Passed Law Clears Way for New Sunscreen Ingredients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/recently-passed-law-clears-way-for-new-sunscreen-ingredients/21232/By forcing the FDA to clear its backlog of sunscreen ingredients pending review, The Sunscreen Innovation Act is a major win for UV protection efforts.Do I Really Need an Investment Advisor?
https://practicaldermatology.com/topics/practice-management/do-i-really-need-an-investment-advisor/21276/The nine reasons physician-investors underperform without professional management.Melanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.